(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma...
| Address | 545 5th Avenue New York, New York 10017 |
| Phone | +1.212.220.9226 |
| Number of Employees | N/A |
| Chairman, President, CEO & Secretary | Shoshana Shendelman |
| Senior Vice President-Finance | Chids Mahadevan |
| Chief Medical Officer | Riccardo Perfetti |
| Chief Commercial Officer | Adam Hansard |
| Price Open | $1.84 |
| Previous Close | $1.76 |
| 52 Week Range | $1.45 - 25.59 |
| Market Capitalization | $45.1 M |
| Shares Outstanding | 26.2 M |
| Sector | Health Technology |
| Industry | Pharmaceuticals: Major | Next Earnings Announcement | 08/11/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$4.11 |
| Beta vs. S&P 500 | N/A |
| Revenue | $0.00 |
| Net Profit Margin | N/A |
| Return on Equity | -106.41% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
